These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20680233)

  • 1. Antiphospholipid syndrome. Current insights into laboratory diagnosis and pathophysiology.
    van Os GM; Urbanus RT; Agar C; Meijers JC; de Groot PG
    Hamostaseologie; 2010 Aug; 30(3):139-43. PubMed ID: 20680233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010.
    Pierangeli SS; de Groot PG; Dlott J; Favaloro E; Harris EN; Lakos G; Ortel T; Meroni PL; Otomo K; Pengo V; Tincani A; Wong R; Roubey R
    Lupus; 2011 Feb; 20(2):182-90. PubMed ID: 21303835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome.
    Urbanus RT; Derksen RH; de Groot PG
    Blood Rev; 2008 Mar; 22(2):93-105. PubMed ID: 17964017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome.
    Devreese K; Hoylaerts MF
    Eur J Haematol; 2009 Jul; 83(1):1-16. PubMed ID: 19226362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European attempts for the standardisation of the antiphospholipid antibodies.
    Tincani A; Filippini M; Scarsi M; Galli M; Meroni PL
    Lupus; 2009 Sep; 18(10):913-9. PubMed ID: 19671792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Laboratory evaluation of lupus anticoagulant in Israel].
    Sarig G; Garach-Jehoshua O; Deutch V; Winder A; Hyam E; Katz BZ; Lahav J; Cassel A; Zivelin A; Souroujon M; Shimron O;
    Harefuah; 2010 May; 149(5):288-90, 336. PubMed ID: 20941871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibodies: evaluation of the thrombotic risk.
    Devreese KM
    Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of antiphospholipid antibody assays. Where do we stand?
    Devreese KM
    Lupus; 2012 Jun; 21(7):718-21. PubMed ID: 22635211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the 2006 revised antiphospholipid syndrome classification criteria.
    Kaul M; Erkan D; Sammaritano L; Lockshin MD
    Ann Rheum Dis; 2007 Jul; 66(7):927-30. PubMed ID: 17337473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-two years of failure to set up undisputed assays to detect patients with the antiphospholipid syndrome.
    de Groot PG; Derksen RH; de Laat B
    Semin Thromb Hemost; 2008 Jun; 34(4):347-55. PubMed ID: 18814068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
    Ieko M; Nakabayashi T; Tarumi T; Yoshida M; Naito S; Atsumi T; Koike T
    Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The geoepidemiology of the antiphospholipid antibody syndrome.
    Biggioggero M; Meroni PL
    Autoimmun Rev; 2010 Mar; 9(5):A299-304. PubMed ID: 19932199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of antiphosphatidylethanolamine antibodies in the so-called "seronegative antiphospholipid syndrome".
    Sanmarco M
    Autoimmun Rev; 2009 Dec; 9(2):90-2. PubMed ID: 19306951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advanced clinical laboratory studies in the graduate school of medicine--studies on pathogenic mechanisms of anti-phospholipid syndrome].
    Nojima J
    Rinsho Byori; 2009 Aug; 57(8):786-92. PubMed ID: 19764414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.